4//SEC Filing
TAKEDA PHARMACEUTICAL CO LTD 4
Accession 0001395064-25-000140
$TAKCIK 0001888012other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:23 AM ET
Size
8.1 KB
Accession
0001395064-25-000140
Insider Transaction Report
Form 4
HilleVax, Inc.HLVX
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Transactions
- Disposition from Tender
Common Stock
2025-09-17$1.95/sh−6,724,000$13,111,800→ 0 total(indirect: See Explanation of Responses)
Takeda Vaccines, Inc.
10% Owner
Transactions
- Disposition from Tender
Common Stock
2025-09-17$1.95/sh−6,724,000$13,111,800→ 0 total(indirect: See Explanation of Responses)
Footnotes (2)
- [F1]These shares were sold pursuant to the cash tender offer (the "Tender Offer") by XOMA Royalty Corporation, a Nevada corporation ("Parent") and XRA 4 Corp., a Delaware corporation and a wholly owned subsidiary of Parent, to purchase all of the outstanding shares of common stock of the Issuer at an offer price of (i) $1.95 per share of common stock and (ii) one non-transferable contractual contingent value right. The Tender Offer expired as scheduled at one minute after 11:59 p.m., Eastern Time, on September 15, 2025 (the "Expiration Time") and closing of the Tender Offer was announced on September 17, 2025. As all conditions to the Tender Offer were satisfied or waived, on September 17, 2025, Parent irrevocably accepted for payment all shares validly tendered into and not validly withdrawn from the Tender Offer and paid for all such shares in accordance with the Tender Offer.
- [F2]Takeda Pharmaceutical Company Limited has beneficial ownership of the reported securities, all of which are held directly by Takeda Vaccines, Inc., an indirect wholly-owned subsidiary of Takeda Pharmaceutical Company Limited. Takeda Vaccines, Inc. is owned directly by Takeda Pharmaceuticals U.S.A., Inc., which is owned directly by both Takeda Pharmaceutical Company Limited (72.70%) and Takeda Pharmaceuticals International AG (27.30%). Takeda Pharmaceuticals International AG is a wholly-owned direct subsidiary of Takeda Pharmaceutical Company Limited.
Documents
Issuer
HilleVax, Inc.
CIK 0001888012
Entity typeother
Related Parties
1- filerCIK 0001395064
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:23 AM ET
- Size
- 8.1 KB